EPILEPSY AND CANNABINOIDS

Epilepsy and cannabinoids

There has been growing interest in the use of cannabis-based products for the treatment of a wide range of diseases, including epilepsy. 

Lire la suite keyboard_arrow_right

Auteur(s) Alexis Arzimanoglou, Ulrich Brandl, Helen J. Cross, Antonio Gil-Nagel, Lieven Lagae, Cecilie Johannessen Landmark, Nicola Specchio, Elizabeth Thiele
Éditeur JOHN LIBBEY (English language)
Date 14/01/2021
Pages 68
Taille 24,0 x 17,0
Type Broché
ISBN 9782742016334

Description détaillée : Epilepsy and cannabinoids

A number of studies were published during the last 5 years demonstrating efficacy of purified CBD for the control of a large spectrum of seizure-types, particularly those observed in severe childhood epilepsies, such as Lennox- Gastaut and Dravet syndromes.

What is the content of "Epilepsy and cannabinoids" ?

This book, co-authored by leaders in the field of epileptology, critically reviews recent data from clinical trials. Authors discuss issues related to pharmacology, drug interactions, efficacy, potential adverse events and long-term effects on development and behaviour.

Child and adult neurologists and all clinicians contributing to epilepsy care will find useful information on the best practices, when using purified CBD for the treatment of drug-resistant epilepsies.

Who are the authors of "Epilepsy and cannabinoids" ?

Alexis Arzimanoglou : Paediatric Clinical Epileptology, Sleep Disorders and Functional Neurology Department, University Hospitals of Lyon, France and Hospital San Juan de Dios Children's Hospital, Barcelona, Spain, Members of the ERN EpiCARE.

Ulrich Brandl : Department of Neuropediatrics, University Hospital Jena, Jena, Germany.

Helen J. Cross : UCL-Institute of Child Health, Great Ormond Street Hospital for Children, Member of the European Reference Network EpiCARE, London & Young Epilepsy, Lingfield, UK.

Antonio Gil-Nagel :Epilepsy Program, Neurology Department, Hospital Ruber Internacional, Madrid, Spain.

Lieven Lage : Paediatric Neurology, UZ Leuven, Member of the European Reference Network EpiCARE, Leuven, Belgium.

Cecilie Johanssen Landmark : Programme for Pharmacy, Faculty of Health Sciences, Oslo Metropolitan University and The National center for epilepsy and Dpt of Pharmacology, Oslo University Hospital, Norway.

Nicola Spechhio : Rare and Complex Epilepsy Unit, Department of Neurosciences, Bambino Gesu Children's Hospital, IRCCS,  Member of the European Reference Network EpiCARE, Rome, Italy

Elizabeth Thiele : Department of Neurology, Massachusetts General Hospital, Boston, USA.

 

 

À PARAÎTRE OU DERNIÈRE PARUTION DANS LA MÊME CATÉGORIE :

Auteur(s): Epilepsy and cannabinoids

Alexis Arzimanoglou

Du même auteur :

28,00 €

Sur commande

Expédition sous 4 à 8 jours

28,00 €

Bénéficiez de la remise de 5% en choisissant le retrait en magasin

 
Livraison à 0.01€ à partir de 35€

d'achats en France Métropolitaine

 
Satisfait ou remboursé

sous 14 jours ouvrés

 
Paiements sécurisés

 
Service client

Lundi au Vendredi : de 10h à 18h30
au 04 67 63 62 19 ou par email